Clinical Trial Update: Nimotuzumab in Combined With Chemoradiotherapy to Treat the Newly Diagnosed Diffuse Intrinsic Pontine Glioma in Children [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating nimotuzumab combined with chemoradiotherapy for newly diagnosed diffuse intrinsic pontine glioma in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Intrinsic Pontine Glioma

Drugs mentioned

• Nimotuzumab (nimotuzumab)

Snippet

Sponsor: Biotech Pharmaceutical Co., Ltd. | Conditions: Diffuse Intrinsic Pontine Glioma | Phase 3 | Status: UNKNOWN